Berelowitz Michael 4
4 · Recro Pharma, Inc. · Filed Mar 13, 2018
Insider Transaction Report
Form 4
Berelowitz Michael
Director
Transactions
- Exercise/Conversion
Common Stock
2018-03-09$2.47/sh+7,500$18,525→ 7,500 total - Exercise/Conversion
Stock Option (right to buy)
2018-03-09−7,500→ 14,500 totalExercise: $2.47Exp: 2024-12-17→ Common Stock (7,500 underlying) - Sale
Common Stock
2018-03-09$10.45/sh−7,500$78,347→ 0 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.411 to $10.5053, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
- [F2]The option vested on December 17, 2015.